Clinical Edge Journal Scan

Inflammatory activity needs careful monitoring in late-onset rheumatoid arthritis


 

Key clinical point: Patients with late-onset rheumatoid arthritis (LORA; disease onset at 60 years) had poor control of inflammation after diagnosis compared with those with young-onset RA (YORA), with late onset being associated with a greater cumulative inflammatory burden over time.

Major finding: Moderate-high inflammatory activity (P = .018) was more frequent in LORA vs YORA. The median C-reactive protein (P = .039) and interleukin-6 (P = .045) levels at onset were significantly higher in patients with LORA vs YORA, and late-onset was significantly associated with a high cumulative inflammatory activity of RA (odds ratio 4.694; P = .008).

Study details: This was a nested cohort study of a prospective cohort including 110 patients with incident RA (LORA n = 22; YORA n = 88) and 110 age- and sex-matched control individuals.

Disclosures: This study was supported by grants from Fondos FEDER, University of Malaga, and other sources. The authors declared no conflicts of interest.

Source: Mena-Vázquez N et al. Inflammatory profile of incident cases of late-onset compared with young-onset rheumatoid arthritis: A nested cohort study. Front Med (Lausanne). 2022;9:1016159 (Nov 8). Doi: 10.3389/fmed.2022.1016159

Recommended Reading

RA risk raised by work-related inhaled agents
MDedge Rheumatology
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
MDedge Rheumatology
Cardiovascular risk score multipliers suggested for rheumatic diseases
MDedge Rheumatology
Leflunomide ups RA-ILD progression risk in patients with severe ILD
MDedge Rheumatology
Baricitinib monotherapy: An attractive option for RA patients with methotrexate intolerance
MDedge Rheumatology
Immunomodulators reduce cardiovascular risk in RA
MDedge Rheumatology
Similar prognosis in late- and younger-onset rheumatoid arthritis
MDedge Rheumatology
Sarilumab improves disproportionate articular pain in RA
MDedge Rheumatology
Methotrexate protective against lung function decline and mortality in patients with RA
MDedge Rheumatology
Anti-protein arginine deiminase antibodies associated with radiographic injury in RA
MDedge Rheumatology